Latest News on AVNS

Financial News Based On Company


Advertisement
Advertisement

Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down

https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.

Avanos Medical ( AVNS ) Q2 Revenue Up 2%

https://www.fool.com/data-news/2025/08/05/avanos-medical-avns-q2-revenue-up-2/
Avanos Medical ( NYSE:AVNS ) , a medical technology firm specializing in digestive health and pain management devices, shared its financial results for Q2 2025 on August 5, 2025. The company delivered GAAP revenue and adjusted earnings surpassed Wall Street estimates, reporting $175.0 million in ...

Avanos ( AVNS ) Q2 2025 Earnings Call Transcript

https://www.fool.com/earnings/call-transcripts/2025/08/05/avanos-avns-q2-2025-earnings-call-transcript/
Image source: The Motley Fool.Need a quote from a Motley Fool analyst? Email [email protected] company closed the sale of its hyaluronic acid product line at the end of July 2025, marking a clear step to concentrate resources on its core Specialty Nutrition Systems and Pain Management and Recovery ...

Avanos Medical ( AVNS ) Misses Q2 Earnings Estimates

https://www.zacks.com/stock/news/2666955/avanos-medical-avns-misses-q2-earnings-estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.56% and +4.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for July 15th

https://www.zacks.com/stock/news/2581794/new-strong-sell-stocks-for-july-15th
DDD, AVNS and BABA have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2025.
Advertisement

Avanos Medical ( AVNS ) International Revenue in Focus: Trends and Expectations

https://www.zacks.com/stock/news/2468050/avanos-medical-avns-international-revenue-in-focus-trends-and-expectations
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

New Strong Sell Stocks for May 9th

https://www.zacks.com/stock/news/2465829/new-strong-sell-stocks-for-may-9th
AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025.

AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down

https://www.zacks.com/stock/news/2464347/avns-stock-gains-post-q1-earnings-revenue-beat-gross-margin-down
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges.

Avanos Medical ( AVNS ) Q1 Earnings and Revenues Top Estimates

https://www.zacks.com/stock/news/2462787/avanos-medical-avns-q1-earnings-and-revenues-top-estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 36.84% and 2.04%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Liberty Energy Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket - Asure Software ( NASDAQ:ASUR ) , Algoma Steel Group ( NASDAQ:ASTL )

https://www.benzinga.com/25/04/44858147/why-liberty-energy-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket
Shares of Liberty Energy Inc. LBRT rose sharply in today's pre-market trading following first-quarter results. Liberty Energy reported quarterly earnings of 4 cents per share which missed the analyst consensus estimate of 5 cents per share.
Advertisement

AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK

https://www.zacks.com/stock/news/2439607/avns-stock-gains-following-direct-sales-deal-for-mic-key-in-the-uk
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025.

Orchestra BioMed Reports Full Year 2024 Financial Results and Provides a Fourth Quarter Business Update

https://www.globenewswire.com/news-release/2025/03/31/3052798/0/en/Orchestra-BioMed-Reports-Full-Year-2024-Financial-Results-and-Provides-a-Fourth-Quarter-Business-Update.html
NEW HOPE, Pa., March 31, 2025 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year ...

Avanos Medical ( AVNS ) Down 5.8% Since Last Earnings Report: Can It Rebound?

https://www.zacks.com/stock/news/2436969/avanos-medical-avns-down-58-since-last-earnings-report-can-it-rebound
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

New Strong Sell Stocks for March 24th

https://www.zacks.com/stock/news/2433876/new-strong-sell-stocks-for-march-24th
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025.

New Strong Sell Stocks for March 18th

https://www.zacks.com/stock/news/2431287/new-strong-sell-stocks-for-march-18th
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025.
Advertisement

Do Options Traders Know Something About Avanos ( AVNS ) Stock We Don't?

https://www.zacks.com/stock/news/2428354/do-options-traders-know-something-about-avanos-avns-stock-we-dont
Investors need to pay close attention to Avanos (AVNS) stock based on the movements in the options market lately.

New Strong Sell Stocks for March 3rd

https://www.zacks.com/stock/news/2424130/new-strong-sell-stocks-for-march-3rd
AVNS, CSX and STZ have been added to the Zacks Rank #5 (Strong Sell) List on March 3, 2025.

AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract

https://www.zacks.com/stock/news/2422829/avns-stock-gains-post-q4-earnings-revenue-beat-margins-contract
Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges.

Avanos Medical ( AVNS ) Q4 Earnings and Revenues Surpass Estimates

https://www.zacks.com/stock/news/2421752/avanos-medical-avns-q4-earnings-and-revenues-surpass-estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 7.50% and 1.06%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Avanos Medical ( AVNS ) Soars 7.2%: Is Further Upside Left in the Stock?

https://www.zacks.com/stock/news/2404532/avanos-medical-avns-soars-72-is-further-upside-left-in-the-stock
Avanos Medical (AVNS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Advertisement

Reasons to Hold Avanos Medical Stock in Your Portfolio Now

https://www.zacks.com/stock/news/2401900/reasons-to-hold-avanos-medical-stock-in-your-portfolio-now
AVNS' strong product line and focus on R&D raise optimism about the stock.

New Strong Sell Stocks for December 11th

https://www.zacks.com/stock/news/2381862/new-strong-sell-stocks-for-december-11th
AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024.

CAH Stocks Gains on Q1 Earnings & Sales Beat and Raised '25 EPS View

https://www.zacks.com/stock/news/2362758/cah-stocks-gains-on-q1-earnings-sales-beat-and-raised-25-eps-view
Cardinal Health's first-quarter fiscal 2025 results benefit from solid Pharmaceutical and Specialty Solutions growth. However, OptumRx contract expiry hurts sales.

Are Investors Undervaluing Avanos Medical ( AVNS ) Right Now?

https://www.zacks.com/stock/news/2361702/are-investors-undervaluing-avanos-medical-avns-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts

https://www.zacks.com/stock/news/2361776/avanos-q3-earnings-meet-estimates-sales-miss-gross-margin-contracts
Strength in AVNS' Digestive Health segment drives its third-quarter performance ...
Advertisement

CONMED Beats on Q3 Earnings, Misses on Sales, Lowers '24 Sales View

https://www.zacks.com/stock/news/2361777/conmed-beats-on-q3-earnings-misses-on-sales-lowers-24-sales-view
CNMD's Q3 earnings beat estimates on the back of higher revenues and lower costs and expenses.

GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up

https://www.zacks.com/stock/news/2360857/ge-healthcare-q3-earnings-beat-estimates-sales-meet-net-margin-up
GEHC's third-quarter results witness declining segmental revenues in imaging and ultrasound, offset by strong Pharmaceutical Diagnostics performance. The bottom line improves on better pricing.

Avanos Medical ( AVNS ) Q3 Earnings Meet Estimates

https://www.zacks.com/stock/news/2360286/avanos-medical-avns-q3-earnings-meet-estimates
Avanos Medical (AVNS) delivered earnings and revenue surprises of 0% and 2.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Inari Medical Q3 Earnings Miss Estimates, Revenues Increase Y/Y

https://www.zacks.com/stock/news/2359770/inari-medical-q3-earnings-miss-estimates-revenues-increase-yy
NARI's third-quarter results witness an increase in revenues with dismal bottom-line performance. Gross margins contract while the company continues to incur operating losses.

TransMedics Stock Falls as Q3 Earnings & Sales Miss Estimates

https://www.zacks.com/stock/news/2359767/transmedics-stock-falls-as-q3-earnings-sales-miss-estimates
TMDX's third-quarter revenues increase with the utilization of the OCS across all three organs and additional revenues generated by its logistics services. Gross margin contracts.
Advertisement

West Pharmaceutical Stock Gains on Q3 Earnings Beat & Raised Guidance

https://www.zacks.com/stock/news/2357120/west-pharmaceutical-stock-gains-on-q3-earnings-beat-raised-guidance
WST's third-quarter results reflect a recovery in the Proprietary Products segment following elevated customer destocking, hurting sales in the second quarter.

Here's Why You Should Retain Inogen Stock in Your Portfolio Now

https://www.zacks.com/stock/news/2353106/heres-why-you-should-retain-inogen-stock-in-your-portfolio-now
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.

Intuitive Surgical Q3 Earnings Beat, Procedures Robust

https://www.zacks.com/stock/news/2353105/intuitive-surgical-q3-earnings-beat-procedures-robust
ISRG's third-quarter results reflect a healthy demand for procedures. Higher pricing boosts procedure sales. An improvement in margins buoys well.

Avanos Medical ( AVNS ) Upgraded to Strong Buy: What Does It Mean for the Stock?

https://www.zacks.com/stock/news/2352575/avanos-medical-avns-upgraded-to-strong-buy-what-does-it-mean-for-the-stock
Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Global Enteral Feeding Devices Market is Projected to Evolve at a Modest 6.1% CAGR through 2031 | SkyQuest Technology

https://www.benzinga.com/pressreleases/24/10/g41289394/global-enteral-feeding-devices-market-is-projected-to-evolve-at-a-modest-6-1-cagr-through-2031-sky
Westford, USA, Oct. 11, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Enteral Feeding Devices market will attain a value of USD 6.6 billion by 2031, with a CAGR of 6.1% over the forecast period ( 2024-2031 ) .
Advertisement

Should Value Investors Buy Avanos Medical ( AVNS ) Stock?

https://www.zacks.com/stock/news/2348187/should-value-investors-buy-avanos-medical-avns-stock
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Reasons to Add Avanos Medical Stock in Your Portfolio Now

https://www.zacks.com/stock/news/2345622/reasons-to-add-avanos-medical-stock-in-your-portfolio-now
AVNS's strong product line and focus on R&D raise optimism about the stock.

Implied Volatility Surging for Avanos ( AVNS ) Stock Options

https://www.zacks.com/stock/news/2344679/implied-volatility-surging-for-avanos-avns-stock-options
Investors need to pay close attention to Avanos (AVNS) stock based on the movements in the options market lately.

Centene's Michigan Unit Partners With Mae to Reduce Health Disparities

https://www.zacks.com/stock/news/2340080/centenes-michigan-unit-partners-with-mae-to-reduce-health-disparities
CNC's Meridian unit collaborates with Mae to improve health outcomes and address health disparities in Michigan.

Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?

https://www.zacks.com/stock/news/2338717/molina-healthcare-stock-rises-154-in-3-months-should-you-buy
MOH stock is expected to benefit from contract wins, rising premiums and expansion initiatives.
Advertisement

Are Investors Undervaluing Avanos Medical ( AVNS ) Right Now?

https://www.zacks.com/stock/news/2338498/are-investors-undervaluing-avanos-medical-avns-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Smart Investors Are Holding Acadia Healthcare Stock Now: Here's Why

https://www.zacks.com/stock/news/2338117/smart-investors-are-holding-acadia-healthcare-stock-now-heres-why
ACHC is expected to benefit from improved volumes, patient day growth and expansion initiatives.

Avanos Medical Stock May Gain From Brand Partnership With NFL

https://www.zacks.com/stock/news/2335445/avanos-medical-stock-may-gain-from-brand-partnership-with-nfl
AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa.

Centene's Unit Secures New Four-Year Medicaid Contract in Iowa

https://www.zacks.com/stock/news/2332403/centenes-unit-secures-new-four-year-medicaid-contract-in-iowa
CNC's unit, Iowa Total Care, wins a new contract to provide Medicaid managed care services, enhancing its presence in Iowa and bringing improved health outcomes in the state.

Acadia Healthcare Expands Behavioral Health Services in Iowa - Acadia Healthcare Co ( NASDAQ:ACHC ) , Avanos Medical ( NYSE:AVNS )

https://www.benzinga.com/news/earnings/24/08/40608967/acadia-healthcare-expands-behavioral-health-services-in-iowa
Acadia Healthcare Company, Inc. ACHC and Methodist Jennie Edmundson Hospital recently conducted a groundbreaking ceremony for a cutting-edge behavioral health hospital in Council Bluffs, IA. Plans to establish the hospital were announced in July 2023 as part of the joint-venture partnership ...
Advertisement

Acadia Healthcare Expands Behavioral Health Services in Iowa

https://www.zacks.com/stock/news/2328512/acadia-healthcare-expands-behavioral-health-services-in-iowa
ACHC breaks ground on a new behavioral health hospital in Council Bluffs, addressing regional care shortages through a joint venture with Methodist Health System.

( AVNS ) - Analyzing Avanos Medical's Short Interest - Avanos Medical ( NYSE:AVNS )

https://www.benzinga.com/insights/short-sellers/24/08/40510520/avns-analyzing-avanos-medicals-short-interest
Avanos Medical's AVNS short percent of float has fallen 8.12% since its last report. The company recently reported that it has 693 thousand shares sold short, which is 2.15% of all regular shares that are available for trading.

Is Avanos Medical ( AVNS ) Stock Undervalued Right Now?

https://www.zacks.com/stock/news/2325608/is-avanos-medical-avns-stock-undervalued-right-now
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Implied Volatility Surging for Avanos ( AVNS ) Stock Options

https://www.zacks.com/stock/news/2320755/implied-volatility-surging-for-avanos-avns-stock-options
Investors need to pay close attention to Avanos (AVNS) stock based on the movements in the options market lately.

Align Technology ( ALGN ) Encounters Low ASP, FX Headwinds

https://www.zacks.com/stock/news/2317163/align-technology-algn-encounters-low-asp-fx-headwinds
Align Technology's (ALGN) Clear Aligner ASP is facing a significant impact of unfavorable foreign exchange across multiple currencies.
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion